☆ 4.6 Article

Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Related references

Note: Only part of the references are listed.

Review Pharmacology & Pharmacy

Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020

Elisabeth Bakker et al.

Summary: Regulatory qualification of biomarkers enables harmonized use in personalized medicine. This study reviews the European Medicines Agency's biomarker qualification procedure and provides insights into its frequency, outcome, challenges, and characteristics. The findings support future applications by understanding the process.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Medical Informatics

Advancing UK Regulatory Science Strategy in the Context of Global Regulation: a Stakeholder Survey

Samantha Cruz Rivera et al.

Summary: 145 participants identified priority areas for UK regulatory science, including flexibility, co-development, responsiveness, speed, reimbursement, and education and professional development. The UK has a critical opportunity to establish its national and international regulatory science leadership by harnessing broader academic input, developing strategic cross-sector collaborations, incorporating patients' experiences and perspectives, and investing in a skilled workforce.

THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2021)

Add to Collection

Article Medicine, Research & Experimental

ReGARDD (Regulatory Guidance for Academic Research of Drugs and Devices): The evolution of a collaborative regional CTSA-funded forum and website for regulatory support

Kimberly A. Brownley et al.

Summary: ReGARDD is a regional forum aimed at providing regulatory guidance to academic researchers, which has organized forums, updated its website, and created educational content and videos to offer users professional support and training opportunities. It has received positive feedback and endorsement from users, helping strengthen regional regulatory workforce and promote best practices in organizational and operational efficiency.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap

Viktoriia Starokozhko et al.

Summary: Truly disruptive medicine innovation often starts in non-commercial research institutions, but lack of mutual understanding between medicine developers and regulators can delay patient access. Regulatory barriers hinder the translational development of novel products or treatment paradigms initiated in academia. The STARS project aims to bridge the regulatory knowledge gap and enhance dialogue to facilitate implementation of academic research findings in clinical practice.

DRUG DISCOVERY TODAY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Regulatory Science and Innovation Programme for Europe (ReScIPE): A proposed model

Philip A. Hines et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Add to Collection

Article Law

Exploring Solutions to Foster ATMP Development and Access to Patients in Europe

Vincenzo Salvatore

EUROPEAN JOURNAL OF HEALTH LAW (2020)

Add to Collection

Review Pharmacology & Pharmacy

Surviving in the Valley of Death: Opportunities and Challenges in Translating Academic Drug Discoveries

Marcus C. Parrish et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)

Add to Collection

Article Cell & Tissue Engineering

Hurdles in clinical implementation of academic advanced therapy medicinal products: A national evaluation

Sofieke de Wilde et al.

CYTOTHERAPY (2016)

Add to Collection

Review Pharmacology & Pharmacy

Development of cell therapy medicinal products by academic institutes

Sofieke de Wilde et al.

DRUG DISCOVERY TODAY (2016)

Add to Collection

Review Pharmacology & Pharmacy

Academic drug discovery: current status and prospects

Jeremy R. Everett

EXPERT OPINION ON DRUG DISCOVERY (2015)

Add to Collection

News Item Biotechnology & Applied Microbiology

REGULATORY WATCH Impact of scientific advice from the European Medicines Agency

Matthias P. Hofer et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Add to Collection

Editorial Material Pharmacology & Pharmacy

The Role of Academic Medical Centers in Advancing Regulatory Science

R. J. Meyer

CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)

Add to Collection

Editorial Material Chemistry, Medicinal

Playing Well with Others! Initiating and Sustaining Successful Collaborations between Industry, Academia and Government

Craig J. Thomas et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)

Add to Collection

Editorial Material Education, Scientific Disciplines

Commentary: Compliance Education and Training: A Need for New Responses in Clinical Research

Mindy J. Steinberg et al.

ACADEMIC MEDICINE (2010)

Add to Collection

Article Pharmacology & Pharmacy

Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency

Jan Regnstrom et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)

Add to Collection

Article Education, Scientific Disciplines

Promoting translational research in academic health centers: Navigating the roadmap

TP Cripe et al.

ACADEMIC MEDICINE (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.